G(-2548)A leptin gene polymorphism in obese subjects is associated with serum leptin concentration and bone mass

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 5, 2010, Pages 175-180

  Franek, Edward ^a,b   Nowak, Jacek ^c   Safranow, Krzysztof ^d   Adler, Grazyna ^d   Bińczak Kuleta, Agnieszka ^d   Ciechanowicz, Andrzej ^d   Wiȩcek, Andrzej ^e  

^a Central Clinical Hospital   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c AMGEN INC   (United States)

^d POMERANIAN MEDICAL UNIVERSITY   (Poland)

^e MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Bone; Leptin; Leptin gene polymorphism; Leptin receptor gene polymorphism

Indexed keywords

CREATININE; DNA; GLUCOSE; INSULIN; LEPTIN; LIPID;

ADULT; ALLELE; ARTICLE; BODY FAT; BONE DENSITY; BONE MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERLEPTINEMIA; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY;

EID: 77953764465     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.919     Document Type: Article

References (25)

1. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med. 1996: 1334: 292-295.
2. Iwamoto I, Fujino T, Douchi T. The leptin receptor in human osteoblasts and the direct effect of leptin on bone metabolism. Gynecol Endocrinol. 2004; 19: 97-104. (Pubitemid 39331410)
3. Karsenty G. Central control of bone formation. In: Gruenfeld JP, Bach JF, Kreis H, eds. Advances in Nephrology. St. Louis, United States: Mosby Inc.; 2001: 119-133.
4. Takeda S, Elefteriou F, Levasseur R, et al. Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002; 111: 305-317. (Pubitemid 35345151)
5. Odabasi E, Ozata M, Turan M, et al. Plasma leptin concentration in postmenopausal women with osteoporosis. Eur J Endocrinol. 2000; 142: 170-173. (Pubitemid 30121031)
6. Iwamoto I, Douchi T, Kosha S, et al. Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women. Acta Obstet Gynecol Scand. 2000; 79: 1060-1064.
7. Ibanez L, Potau N, Ong K, et al. Increased bone mineral density and serum leptin in non-obese girls with precious pubarche: relation to low birthweight and hyperinsulinism. Horm Res. 2000; 54: 192-197.
8. Pasco JA, Henry MJ, Kotowicz MA, et al. Serum leptin levels are associated with bone mass in non-obese women. J Clin Endocrinol Metab. 2000; 86: 1884-1887.
9. Thomas T, Burguera B, Melton LJ, et al. Role of serum leptin, insulin and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone. 2001; 29: 114-120.
10. Yamauchi M, Sugimoto T, Yamaguchi T, et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol. 2001; 55: 341-347.
11. Blain H, Vuillemin A Guillemin F, et al. Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab. 2002; 87: 1030-1035.
12. Hadji P, Bock K, Gotschalk M, et al. The influence of serum leptin concentration on bone mass assessed by quantitative uktrasonometry in pre and postmenopausal women. Maturitas. 2003; 44: 141-148.
13. Roemmich JN, Clark PA, Mantzoros CS, et al. Relationship of leptin to bone mineralization in children and adolescents. J Clin Endocrinol Metabol. 2003; 88: 599-604.
14. Blum M, Harris SS, Must A, et al. Leptin, body composition and bone mineral density in premenopausal women. Calcif Tissue Int. 2003; 73: 27-32.
15. Ormarsdottir S, Ljunggren O, Mallmin H, et al. Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver disease. J Gastroenterol Hepatol. 2001; 16: 1409-1412.
16. Sato M, Takeda N, Sarui H, et al. Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab. 2001; 86: 5273-5276.
17. Ruhl CE, Everhart JE. Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res. 2002; 17: 1896-1903.
18. Ushiroyama T, Ikeda A, Hosotani T, et al. Inverse correlation between serum leptin concentration and vertebral bone density in postmenopausal women. Gynecol Endocrinol. 2003; 17: 31-36.
19. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996; 348: 159-161.
20. Mammes O, Betoulle D, Aubert R, et al. Association of the G-2548A polymorphism in the 5′ region of the LEP gene with overweight Ann Hum Gen. 2000; 64: 391-394.
21. Paracchini V, Pedotti P, Taioli E. Genetics of leptin and obesity: a HuGE review. Am J Epidemiol. 2005; 162: 101-114.
22. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Amer P. A polymorphism in the leptin promoter region (-2548 G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res. 2002; 34: 355-359.
23. Thompson DB, Ravussin E, Bennett PH, Bogardus C. Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet 1997; 6: 675-679.
24. Mammes O, Betoulle D Aubert R, et al. Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes. 1998; 47: 487-489.
25. Le Sturrff C, Le Bihan C, Schork NJ, Bougneres P. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat in obese girls. Diabetes. 2000; 49: 2196-2200.